Bellinzona, Switzerland

Lisa Perruzza

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lisa Perruzza: Innovator in Antibody Research

Introduction

Lisa Perruzza is a prominent inventor based in Bellinzona, Switzerland. She has made significant contributions to the field of biomedical research, particularly in the development of antibodies. Her work focuses on creating innovative solutions to combat infections, showcasing her dedication to advancing healthcare.

Latest Patents

Lisa Perruzza holds 1 patent related to antibodies against specific infections. The patent provides antibodies and antigen-binding fragments that are capable of neutralizing infections in subjects. In certain embodiments, the antibody or antigen-binding fragment comprises an IgA antibody, such as a secretory IgA antibody. The patent also includes pharmaceutical compositions that utilize these antibodies and methods for treating or preventing infections in subjects. Notably, recombinant secretory IgA antibodies can be administered orally to individuals at risk of developing infections.

Career Highlights

Throughout her career, Lisa has worked with notable organizations, including Humabs Biomed SA and the Institute for Research in Biomedicine. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Lisa has collaborated with esteemed colleagues such as Matteo Samuele Pizzuto and Fabio Benigni. These partnerships have further enriched her research and innovation in antibody development.

Conclusion

Lisa Perruzza's work in antibody research exemplifies her commitment to improving health outcomes through innovative solutions. Her contributions to the field are invaluable and continue to inspire future advancements in biomedical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…